STAGE IVA SINONASAL CANCER AJCC V8
Clinical trials for STAGE IVA SINONASAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA SINONASAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA SINONASAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink sinonasal tumors before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether adding the immunotherapy drug cemiplimab to standard chemotherapy (carboplatin and paclitaxel) before surgery can improve outcomes for people with sinonasal squamous cell carcinoma. About 108 participants with stage III or IV disease will be …
Matched conditions: STAGE IVA SINONASAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis early-phase study tests whether adding the experimental drug ipatasertib to standard chemotherapy and radiation is safe and effective for people with advanced head and neck cancer. Ipatasertib may help stop cancer cell growth. About 46 participants will receive the combinati…
Matched conditions: STAGE IVA SINONASAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
New drug plus precision radiation aims to tame recurrent head and neck cancer
Disease control Recruiting nowThis early-stage trial tests a drug called camonsertib combined with precise radiation for head and neck cancer that has returned or cannot be surgically removed. The study aims to find the safest dose and see if the combination can control tumor growth. About 39 adults with cert…
Matched conditions: STAGE IVA SINONASAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC